Revolution Medicines logo

Director, US Lung Market Research

Revolution Medicines

Redwood City, CAHybridPosted 19 days ago$211,000 - $264,000/year
Full TimeDirector & AboveCommercial & Pharma SalesBiotechnology
Original posting ↗

Summary

Reporting to the Executive Director, US Lung Analytics & Insights, the Director, US Lung Market Research will serve as the US Market Research lead for Revolution Medicines' Lung cancer portfolio. This role will partner closely with US Commercial, US Market Access, Global Insights, Medical Affairs, Clinical Development, and Business Operations to generate actionable insights that inform portfolio strategy, launch readiness, commercialization planning, and business performance. The role requires a strong understanding of the NSCLC cancer treatment landscape, patient journey, biomarker-driven markets, and oncology data assets.

Job description

Responsibilities

  • Leads, designs, and executes US primary market research projects with HCPs, patients, and payors
  • Initiates and facilitates activities that enhance partners' knowledge regarding the relevant US market and potential product attitudes, usage, market dynamics, and competition (for example, development of treatment flows, target product profiles, opportunity assessments, and market landscape research).
  • Shares the voice of the US community (e.g., physicians, patients, payors) to the organization by maintaining and communicating a holistic understanding of the marketplace synthesized from primary and secondary sources.
  • Reinforces market research best practices, identify market research and data sources, vendor options, and methodologies that are best suited to address a business need.
  • Manages third parties associated with this function.
  • Communicates and aligns key internal stakeholders around market research objectives and outputs including qualifying the results based on the strength of the data and identifying limitations.
  • Develops and presents timely final reports and actionable recommendations to key stakeholders, focusing on key findings and relevant implications to each stakeholder group, and senior leadership.
  • Communicate insights and strategic implications to senior leadership through clear, concise, and compelling recommendations.
  • Shapes situation analysis as a part of launch planning to provide a comprehensive understanding of the market.
  • Partner with cross-functional teams like marketing, sales (when appropriate), access, and medical to provide a clear view of the market.
  • Demonstrates the ability to quickly understand complex markets, disease states, competitive landscapes, and relevant market and managed care dynamics.
  • Exhibits analytical rigor in the valuation of business opportunities and the quantification of risk.
  • Partner with US Forecasting, US Data Analytics, and Competitive Intelligence colleagues to develop an integrated view of market performance and future growth opportunities.
  • Travels as needed.

Required Skills, Experience and Education

  • Bachelor's degree required (advanced degree preferred) with 10+ years of progressive experience in a pharmaceutical, biotechnology, or strategic consulting role with 6+ years of experience in a strategic analytics role.
  • Oncology market research experience required; NSCLC cancer experience strongly preferred.
  • Experience in market development and new product launches.
  • Extensive primary research and secondary analytical skills required; ability to translate the data and learning into actionable recommendations for business growth.
  • Track record of being a collaborative team player, and adaptive to meet the needs of a growing business
  • Strong problem solver with experience leveraging a variety of research and analytical vendors, study designs, and building quality research vendor partnerships
  • Demonstrated ability to influence senior management and key business partners.
  • Proven experience in a smaller, rapidly growing, company.
  • Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
  • Ability to represent Revolution Medicines well with internal and external stakeholders, including strong interpersonal skills including verbal and written communication.
  • Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients.

Preferred Skills

  • MBA, MPH, MS, or PhD.
  • Deep understanding of NSCLC and biomarker-driven oncology markets.
  • Experience supporting targeted oncology therapies.
  • Prior experience in a growth-stage biotechnology company.

Requirements

  • Bachelor's degree required (advanced degree preferred)
  • 10+ years of progressive experience in a pharmaceutical, biotechnology, or strategic consulting role
  • 6+ years of experience in a strategic analytics role
  • Oncology market research experience required
  • NSCLC cancer experience strongly preferred
  • Experience in market development and new product launches
  • Extensive primary research and secondary analytical skills required
  • Ability to translate data and learning into actionable recommendations for business growth
  • Track record of being a collaborative team player
  • Strong problem solver with experience leveraging a variety of research and analytical vendors, study designs, and building quality research vendor partnerships
  • Demonstrated ability to influence senior management and key business partners
  • Proven experience in a smaller, rapidly growing company
  • Excellent organizational skills and ability to prioritize effectively
  • Strong interpersonal skills including verbal and written communication
  • Entrepreneurial mindset with tolerance for ambiguity
  • MBA, MPH, MS, or PhD preferred
  • Deep understanding of NSCLC and biomarker-driven oncology markets preferred
  • Experience supporting targeted oncology therapies preferred
  • Prior experience in a growth-stage biotechnology company preferred

Benefits

  • Competitive cash compensation
  • Equity awards
  • Health benefits
  • Learning and development opportunities

Company overview

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.